Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.07 BRL | +0.40% | +0.33% | +14.25% |
05-28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
05-28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- AMGN Stock
- AMGN34 Stock
- Charts Amgen Inc.